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Background: Toll-like receptors (TLRs) have been extensively 
studied in recent years. However, functions of these mole-
cules in murine B cell biology are largely unknown. A TLR4 
stimulant, LPS is well known as a powerful polyclonal activa-
tor for murine B cells. Methods: In this study, we explored the 
effect of a murine TLR9 stimulant, M6-395 (a synthetic CpG 
ODNs) on B cell proliferation and Ig production. Results: 
First, M6-395 was much more potent than LPS in augment-
ing B cell proliferation. As for Ig expression, M6-395 facili-
tated the expression of both TGF-β1-induced germ line 
transcript α (GLTα) and IL-4-induced GLTγ1 as levels as 
those by LPS and Pam3CSK4 (TLR1/2 agonist) : a certain Ig 
GLT expression is regarded as an indicative of the corre-
sponding isotype switching recombination. However, IgA and 
IgG1 secretion patterns were quite different--these Ig iso-
type secretions by M6-395 were much less than those by 
LPS and Pam3CSK4. Moreover, the increase of IgA and 
IgG1 production by LPS and Pam3CSK4 was virtually abro-
gated by M6-395. The same was true for the secretion of 
IgG3. We found that this unexpected phenomena provoked 
by M6-395 is attributed, at least in part, to its excessive mi-
togenic nature. Conclusion: Taken together, these results 
suggest that M6-395 can act as a murine polyclonal activator 
but its strong mitogenic activity is unfavorable to Ig isotype 
switching.
[Immune Network 2012;12(1):27-32]
INTRODUCTION
All living organisms are exposed constantly to microorgani-
sms that are present in the environment and need to cope 
with invasion of these organisms into the body. Toll-like re-
ceptors  (TLRs)  are  of  interest  to  immunologists  because  of 
their front-line role in the initiation of innate immunity against 
invading pathogens (1). Engagement of TLRs by the cognate 
antigen triggers clonal expansion of the lymphocyte and fur-
ther production of antigen-specific antibodies. TLR1 and TLR2 
sense bacterial triacylated lipopeptides, while TLR4 and TLR9 
recognizes LPS and CpG-containing DNA motifs, respectively 
(1). Among these, TLR9 is expressed in the endoplasmic retic-
ulum  and  recruited  to  endosomal/lysosomal  compartments 
once  stimulated  (2).
    Recent studies reveal that TLR stimulation on B cells can 
control isotype switching. TLR and MyD88 are required for 
class switching to the pathogenetic IgG2a and IgG2b isotypes 
but not for development of IgM autoantibodies (3). TLR9 can 
r e g u l a t e  i s o t y p e  s w i t c h i n g  t o  I g G 2 a  d i r e c t l y  b y  i n t e r a c t i n g  
with B cells rather than indirectly by inducing Th1 responses 
(4).  Furthermore,  CpG,  but  not  LPS,  upregulates  T-bet  ex-
pression in B cells and induces IgG2a whereas it decreases 
IgG1 and IgE production (5). Other than these studies, the 
exact role of TLR-9 in Ig synthesis has not been thoroughly 
investigated  yet.  Nevertheless, T L R 9  l i g a n d s  w o u l d  b e  r e -
garded as the vaccine adjuvant since it enables B cells to stim-
ulate  Ig  syntheses.
    Recently,  it  has  been  demonstrated  that  a  synthetic  CpG 
oligodeoxynucleotide (ODN) M6-395 function as TLR9-speci-
fic ligands, making them useful in the study of TLR9 function-
ality and signaling in mice (6). In the present study, we inves-M6-395 Is a Mouse B Cell Polyclonal Activator
Mi-Hee Park, et al.
28 IMMUNE NETWORK http://www.ksimm.or.kr Volume 12 Number 1 February 2012
tigated the functions of M6-395 in the context of Ig synthesis 
paralleling with LPS and Pam3CSK4 (TLR1/2 ligand). In es-
sence, we found that M6-395 can act as a B cell polyclonal 
activator  and  that it  is  much  more mitogenic than  LPS  and 
Pam3CSK4.
MATERIALS AND METHODS
Animals
BALB/C  mice  were  purchased f r o m  D a e h a n  B i o l i n k  C o .  
(Seoul, Korea) and maintained on an 8：16 h light：dark cy-
cle in an animal environmental control chamber (Myung Jin 
Inst. Co., Seoul, Korea). Animal care was in accordance with 
the  institutional  guidelines  of  Kangwon  National  University. 
Eight-  to  twelve-week-old  female  mice  were  used  in  this 
study.
Reagents
TGF-β1  and  IL-4  were  purchased  from  R&D  Systems 
(Minneapolis, MN, USA). 2,2'-Azinobis-(3-ethylbenzthiazoline 
sulphonic  acid)  (ABTS)  and  LPS  (Escherichia  coli  0111:B4) 
was  from  Sigma  Chemical  Co.  (St.  Louis,  MO,  USA). 
Pam3CSK4  was  from  Invivogen  (San  Diego,  CA,  USA). 
TRIZOL reagent and CFSE kit were purchased from Invitrogen 
Life Technologies (Carlsbad, CA, USA). The antibodies used 
in  ELISA  were  purchased  from  Southern  Biotechnology 
(Birmingham,  AL).
B cell preparations and cell culture
Mouse spleen B cell population was prepared as described 
before  (7).
    A total of 2×10
6 cells/well were cultured in flat-bottomed, 
24-well tissue culture plates (SPL, Korea) in a volume of 2 
ml complete medium or a total of 2×10
5 cells/well were cul-
tured in flat-bottomed, 96-well tissue culture plates in a vol-
ume  of  200μl  complete  medium  with  added  stimulants.
Isotype-specific ELISA
Produced  antibodies  were  detected  by  using  a  modified 
ELISA (8). Isotype specificity was confirmed by assaying iso-
type-specific antibodies against a panel of myeloma proteins 
o f  t h e  I g G  i s o t y p e s ,  I g A  a n d  I g M .  T h e  a s s a y  w a s  s e n s i t i v e 
to  antibody  concentrations  of  1  to  10  ng/ml.
RNA preparation and RT-PCR
RNA  preparation,  reverse  transcription,  and  PCR  were  per-
formed as described previously (7). PCR primers were synthe-
sized by Bioneer Corp. (Seoul, Korea): TLR1 sense, 5'-GTT 
GTC ACT GAT GTC TTC AGC-3' and antisense, 5'-GCT GTA 
CCT TAG AGA ATT CTG-3'; TLR2 sense, 5'-TGG TGT CTG 
GAG TCT GCT GTG-3' and antisense, 5'-CGC TCC GTA CGA 
AGT TCT CAG-3'; TLR4 sense, 5'-CAG TGG TCA GTG TGA 
TTG TGG-3' and antisense, 5'-TTC CTG GAT GAT GTT GGC 
AGC-3'; TLR9 sense, 5'-CCC TCC TGG TAG AGG CTG C-3' 
and antisense, 5'-TCT TGT AGT AGC AGT TCC CG-3'; GLTα 
sense, 5'-CAA GAA GGA GAA GGT GAT TCA G-3' and anti-
sense,  5'-GAG  CTG  GTG  GGA  GTG  TCA  GTG-3';  GLTγ1 
s e n s e ,  5 ' - C A G  C C T  G G T  G T C  A A C  T G - 3 '  a n d  a n t i s e n s e ,  
5'-CTG TAC ATA TGC AAG GCT-3'; AID sense, 5'-TGC TAC 
GTG GTG AAG AGG AG-3' and antisense 5'-TCC CAG TCT 
GAG ATG TAG CG-3'; β-actin sense, 5'-CAT GTT TGA GAC 
CTT CAA CAC CCC-3' and antisense, 5'-GCC ATC TCC TGC 
TCG AAG TCT AG-3'. PCR reactions for β-actin were per-
formed in parallel in order to normalize cDNA concentrations 
within each set of samples. PCR products were separated on 
a 2% agarose gel and photographed. Band intensities were 
quantified using Scion Image software (Scion Corp., Freder-
ick,  MD,  USA).
Labeling with CFSE
Isolated splenic B cells were labeled with a CFSE kit accord-
ing to the manufacturer’s instructions. Dilution of CFSE was 
measured  by  counting  20,000  cells  (live  gated)  with  a 
FACSCalibur.
RESULTS AND DISCUSSION
M6-395 enhances the viability and proliferation of 
mouse B cell
Toll-like receptor plays an  important role  in the biology of 
B cells (9). First of all, we found that TLR1, TLR2, TLR4, and 
TLR9 were expressed in mouse B cells at the transcriptional 
level (Fig. 1A). LPS, a TLR4 stimulant, is a powerful mitogen 
for murine B cells. Therein, we examined the mitogenic effect 
of M6-395 on the viability of mouse B cells paralleling with 
LPS. LPS, at  the concentration of  12.5μg/ml,  markedly  in-
c r e a s e d  B  c e l l  v i a b i l i t y  u p  t o  d a y  4  ( F i g .  1 B ) .  H e r e i n ,  1 0 0 
nM of M6-395 was comparable to 12.5μg/ml of LPS in the 
increment of cell viability. In fact, the former appears to be 
m o r e  m i t o g e n i c  a g a i n s t  m o u s e  B  c e l l s  t h a n  t h e  l a t t e r  s i n c e 
it took 3 days for M6-395 and 4 days for LPS to reach the 
maximal  viability.  We  further  characterized  the  mitogenic M6-395 Is a Mouse B Cell Polyclonal Activator
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Figure 1. Effect of M6-395 on the 
viability and proliferation of mouse 
spleen B cells. (A) TLR expression 
was detected by RT-PCR in BALB/C
mouse spleen B cells. (B) Mouse 
spleen B cells were cultured with 
LPS (12.5μg/ml) and M6-395 (20 
nM, 100 nM). Cell viability was 
assessed using trypan blue staining. 
(C) Mouse spleen B cells were 
cultured with LPS (12.5μg/ml), 
Pam3CSK4 (0.5μg/ml) and M6-395
(100 nM). B cell proliferation was 
assessed after 2 and 3 days 
analyzing the dilution of CFSE.
Figure 2. Effect of M6-395 on Igs 
production and AID expression. 
Mouse spleen B cells were cultured
with LPS (12.5μg/ml), Pam3CSK4 
(0.5μg/ml) and M6-395 (100 nM) 
for 7 days or 48 h. (A) Supernatants
were collected, and Igs productions 
were determined by isotype-specific
ELISA. Data are means of triplicate 
samples±SEM. (B) Levels of AID 
and  β-actin were measured by 
RT-PCR after 48 h.M6-395 Is a Mouse B Cell Polyclonal Activator
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Figure 3. Effect of TGF-β1, IL-4 on 
expression of M6-395-stimulated 
germline transcripts and Ig produc-
tion. Mouse spleen B cells were 
cultured with LPS (12.5μg/ml), 
Pam3CSK4 (0.5μg/ml) and/or M6- 
395 (100 nM) and stimulated with 
TGF-β1 (0.2 ng/ml) or IL-4 (10 ng/ 
ml) for 48 h or 7 days. (A) Levels of
germline transcript (GLT) α, GLTγ1,
and β-actin were measured by RT- 
PCR. (B) Supernatants were collect-
ed and Igs productions were deter-
mined by isotype-specific ELISA. 
Data are means of triplicate sam-
ples±SEM.
property  of  M6-395  by  CFSE  assay.  In  this,  Pam3CSK4  (a 
TLR1/2 stimulant) was also included since it was expressed 
in  B  ce ll s (F i g . 1 ) an d  th u s e x pe ct e d t o  be  st im u lat o ry  fo r 
B cells. As shown in Fig. 1C, M6-395 stimulated B cell pro-
liferation  much  better  than  LPS  or  Pam3CSK4.  This  finding 
was consistent with the earlier report that CpG promotes cell 
cycle  entry  and  cell  survival  (10).
Effect of M6-395 on the expression of Ig isotypes 
and AID in mouse B cells
Since  M6-395  strongly  increased  B  cell  proliferation,  it  was 
important  to  explore  whether  it  affects  Ig  production  by  B 
cells. As shown in Fig. 2A, we found that M6-395 facilitated 
secretion  of  IgM,  IgG  subclasses,  and  IgA.  However,  the 
amounts of each Ig in the presence of M6-395 were less than 
those in the presence of LPS or Pam3 CSK4. Subsequently, 
we  examined  if  M6-395  can  regulate  expression  of  activa-
tion-induced cytidine deaminase (AID), which is a critical en-
zyme for general class switching recombination (CSR) from 
IgM  to  other  Ig  isotypes  (11,12).  As  shown  in  Fig.  2B, 
M6-395,  like  LPS  and  Pam3CSK4,  clearly  induced  AID  ex-
pression at the transcriptional level. These results indicate that M6-395 Is a Mouse B Cell Polyclonal Activator
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Figure 4. Effect of LPS and/or M6-395 on proliferation of mouse spleen B cells. Mouse spleen B cells were then cultured with LPS (12.5μg/ml)
and/or M6-395 (100 nM). B cell proliferation was assessed after 3 days analyzing the dilution of CFSE.
M6-395  enhances  IgG  and  IgA  secretion,  at  least  in  part, 
through  AID-mediated  Ig  CSR.
Effect of M6-395 on TGF-β1-inducible IgA and 
IL-4-inducible IgG1 CSR
Since  M6-395  can  enhance  Ig  CSR  as  shown  in  Fig.  2A,  it 
was necessary to determine whether M6-395 supports a cer-
tain  cytokine-specific  Ig  CSR.  TGF-β1  and  IL-4  are  potent 
IgA  and  IgG1  switching  factors,  respectively  (13,14).  Given 
that the expression of a particular Ig germline transcript (GLT) 
is considered to be an indicative of such Ig CSR (15), we ex-
amined  the  effects  of  M6-395  on  TGFβ1-inducible  GLTα 
and IL-4-inducible GLTγ1 expression. M6-395, like LPS and 
Pam3CSK4,  well  supported  both  cytokine-induced  GLT  ex-
pression, indicating that M6-395 has an activity to induce Ig 
CSR (Fig. 3A). Interestingly, the increasing GLTα and GLTγ1 
expression by M6-395 was not further augmented in the pres-
ence  of  additional  LPS  or  Pam3CSK4,  suggesting  that  the 
three reagents may share common pathway toward general 
Ig  CSR  event.
  O n  t h e  o t h e r  h a n d ,  b o t h  T G F β1-induced  IgA  secretion 
and  IL-4-induced  IgG1  secretion  were  apparently  increased 
by M6-395 but the amounts of each isotype were much less 
than those by LPS and Pam3CSK4 (Fig. 3B). Moreover, the 
striking increase of IgA and IgG1 by either LPS or Pam3CSK4 
were virtually abolished in the presence of additional M6-395. 
These are totally unexpected results, which are also sharply 
contrasted to those seen in expression patterns of GLTα and 
GLTγ1. This inhibitory effect of M6-395 was more dramatic 
i n  I g G 3  s e c r e t i o n  b y  L P S  a n d  P a m 3 C S K 4  ( F i g .  3 B ) .
    We  speculated  that  the  inhibitory  function  of  M6-395  in 
LPS-  and  Pam3CSK4-stimulated  Ig  production  is  at  least  in 
part owing to an inherent anti-proliferative activity of M6-395. 
Therein, the present study tested the combined effect of LPS 
and M6-395 on the proliferation of splenic B cells. As shown 
in Fig. 4, proliferation of B cells treated with LPS plus M6-395 
was greater than that of LPS and M6-395 each alone. Taken 
together,  an  excess  cell  proliferation-promoting  nature  of 
M6-395 is certainly unfavorable toward B cell differentiation 
into  Ig  synthesis.
Concluding remarks
In the present study, we found that M6-395, a newly identi-
fied  TLR9  stimulant,  is  a  powerful  polyclonal  activator  for 
mouse B cells. Surprisingly, this property of M6-395 is even 
greater  than  that  of  LPS,  a  well-known  B  cell  polyclonal 
activator. Nevertheless, we also realized that this strong pro-
liferation enhancing activity of M6-395 is detrimental for the 
ultimate  Ig  synthesis  though  Ig  CSR  event  is  little  affected. 
Taken  together,  the  results  from  the  present  study  indicate 
that M6-395 could be utilized for a direct B cell adjuvant for 
vaccination. To optimize this adjuvant activity of M6-395, one 
should consider the dynamics between proliferation and dif-
ferentiation  of  B  cells  initiated  by  this  chemical.
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